BiotechTube
Spectrus

Spectrus

Cambridge, United States· Est.
spectruscorp.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2018 and headquartered in Cambridge, Massachusetts, Spectrus operates as a specialized mass spectrometry CRO. The company offers a comprehensive suite of analytical services centered on liquid chromatography/mass spectrometry (LC/MS) to support biotech R&D, with a focus on proteomics, metabolomics, and biomolecule characterization. Its value proposition is providing biotech companies with access to high-end instrumentation and expert analysis without the capital expenditure and operational overhead. Spectrus has recently expanded its offerings to include GLP and GMP-compliant services, positioning it to support later-stage development and regulatory submissions for its clients.

AI / Machine LearningDrug Delivery

Technology Platform

Integrated mass spectrometry service platform utilizing liquid chromatography/mass spectrometry (LC/MS) for 'omics and biomolecule characterization, supported by expert method design, sample processing, data analysis, and regulatory-compliant reporting.

Opportunities

The expansion into GLP and GMP-compliant services opens the significant and sticky market of late-stage preclinical and clinical development support, providing more predictable, long-term revenue.
The growing reliance of biotech on outsourced, specialized 'omics expertise and the capital efficiency of the CRO model present a strong tailwind in the innovation-rich Cambridge ecosystem.

Risk Factors

Revenue is vulnerable to downturns in biotech R&D funding and client concentration.
The capital-intensive need to maintain state-of-the-art instrumentation poses a constant financial burden.
Intense competition from both large full-service CROs and niche specialists requires continuous differentiation on quality and expertise.

Competitive Landscape

Spectrus competes in the specialized mass spectrometry CRO segment against other niche providers and the large-scale, full-service CROs that offer analytical services as part of a broader suite. Its differentiation is its deep focus on mass spec, combined scientific and operational leadership, and recent foray into regulatory-compliant work. Success hinges on outperforming on data quality, scientific insight, and customer service.

More companies in Diagnostics & Precision Medicine →More companies in United States →